HOXB9 promotes osteosarcoma cell survival and malignancy under glucose starvation via upregulating SPP1 expression
Biochemical Pharmacology · 2024
DOI: 10.1016/j.bcp.2024.116208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Jian Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, 116044, PR China; Dalian NO.3 People's Hospital, Department of Orthopedi…. Hauptthemen laut MEDLINE: Osteosarcoma, Glucose, Up-Regulation, Homeodomain Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Liaoning Provincial Natural Science Foundation, National Natural Science Foundation of China, Dalian Science and Technology Bureau.
Abstract (Originalsprache)
Homeobox B9 (HOXB9) has been shown to play a critical role in several tumors. However, the precise biological mechanisms and functions of HOXB9 in osteosarcoma remain largely unknown. In this study, we found that HOXB9 was increased upon glucose starvation. Elevated HOXB9 suppressed osteosarcoma cell death and supported cell growth and migration under glucose starvation. Further mechanistic studies demonstrated that HOXB9 directly bound to the promoter of secreted phosphoprotein 1 (SPP1) and transcriptionally upregulated SPP1 expression which then led cell death decrease and cell growth increase under glucose deprivation environment. Clinically, HOXB9 was significantly upregulated in osteosarcoma compared with normal tissues and increase of HOXB9 expression was positively associated with the elevation of SPP1 in osteosarcoma. Overall, our study illustrates that HOXB9 contributes to malignancy in osteosarcoma and inhibits cell death through transcriptional upregulating SPP1 under glucose starvation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, 116044, PR China; Dalian NO.3 People's Hospital, Department of Orthopedics, Dalian, Liaoning, 116044, PR China.
- The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, 116044, PR China; College of Stomatology Dalian Medical University, Dalian, Liaoning, 116044, PR China.
- The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, 116044, PR China.
- School of Life Sciences, Yantai University, Yantai, Shandong, 264005, PR China.
- Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, 116044, PR China.
- The Second Affiliated Hospital, Dalian Medical University, Dalian, Liaoning, 116044, PR China. Electronic address: zhaowenzhi@dmu.edu.cn.
Förderung
- Liaoning Provincial Natural Science Foundation
- National Natural Science Foundation of China
- Dalian Science and Technology Bureau
- Foundation of Liaoning Province Education Administration
Zitieren
APA
Han, J., Ji, R., Zheng, S., Xia, X., Du, W., He, H., Han, C., Zhao, W., Li, X., Wang, Y., & Zhang, L. (2024). HOXB9 promotes osteosarcoma cell survival and malignancy under glucose starvation via upregulating SPP1 expression. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116208
Vancouver
Han J, Ji R, Zheng S, Xia X, Du W, He H, et al. HOXB9 promotes osteosarcoma cell survival and malignancy under glucose starvation via upregulating SPP1 expression. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116208
BibTeX
@article{Han2024,
author = {Han, Jian and Ji, Renchen and Zheng, Shuo and Xia, Xin and Du, Wenxiao and He, Hongtao and Han, Chuanchun and Zhao, Wenzhi and Li, Xiaojie and Wang, Yuan and Zhang, Lu},
title = {HOXB9 promotes osteosarcoma cell survival and malignancy under glucose starvation via upregulating SPP1 expression},
journal = {Biochemical Pharmacology},
year = {2024},
doi = {10.1016/j.bcp.2024.116208}
}
EUVIMED